RCL — Royal Caribbean Cruises Ltd.

The tape, not the fundamentals, is driving sentiment as of 2026-09-13: -15.5% over one month, -11.6% over three months, and RSI at 24.4 while price sits 7.1% below the 20-day, 11.2% below the 50-day and 9.7% below the 200-day. That de-rating happened AFTER the 2026-07-28 Q2 beat (adjusted EPS $4.21 vs. ~$3.93-$3.98 consensus) and the guidance raise, so it is a multiple-compression event, not an earnings downgrade cycle. Likely drivers: management trimmed FY revenue growth guidance from ~10% to ~9% on localized booking moderation in Mediterranean/Middle East itineraries, Q2 fuel expense rose year-over-year, and a high-beta (1.75) premium-travel name gets sold first in risk-off rotation. Sell-side remains constructive — consensus rating Buy, average target $348.09 (recent average $367.57), implying ~34% upside — but the rating mix is soft (25 buy, 21 hold, 6 sell of 52), so this is a market that has lost conviction on the multiple, not on the business.

Revenue growth is clearly decelerating: +13.2% YoY in Q4 2025 ($4,259M), +11.3% in Q1 2026 ($4,452M), then +6.5% in Q2 2026 ($4,832M vs. $4,538M) — roughly half the pace of two quarters earlier, consistent with the FY revenue growth guidance cut from ~10% to ~9%. More importantly, Q2 2026 was the first genuine YoY crack in profitability in over two years: operating income of $1,307M was DOWN 1.7% YoY (margin 27.0% vs. 29.3%, ~230bps compression) and net income of $1,128M was DOWN 6.8% YoY, with diluted EPS of $4.20 vs. $4.41. That follows a strong run — Q1 2026 operating margin expanded ~250bps YoY (26.1% vs. 23.6%), Q4 2025 expanded ~530bps (21.9% vs. 16.6%), and Q3 2025 was flat (33.1% vs. 33.4%). Gross margin also slipped in the latest quarter (47.3% vs. 49.7% a year earlier), pointing to cost/fuel pressure rather than pricing collapse. Read: the post-COVID margin-recovery supercycle is maturing, not reversing. One watch item — the raised FY2026 EPS guide of $17.73-$17.87 implies H2 2026 EPS of roughly $10.05-$10.19 after $7.68 in H1 (+8% YoY), i.e. mid-to-high-teens H2 growth versus a ~$6.32 Q3 consensus print (2026-10-27). Full-year guidance therefore requires a back-half acceleration H1 did not deliver; if Q3 disappoints, the deceleration thesis hardens.

Modestly cheap, but cheap for a reason. As of 2026-09-13 at $260.14, RCL trades at 15.99x trailing EPS of $16.364 versus a 3-year average trailing P/E of 19.41x — an ~18% discount to its own history. On forward numbers it's cheaper still: FY2026E EPS of $17.76 implies 14.65x. PEG of 0.747 and P/S of 3.735 versus a 5-year average of 4.86x both screen cheap, and EV/EBITDA of 12.87x is undemanding for a business earning a 14.9% ROIC on a 27.3% operating margin. The counterweights: P/B of 6.84x is optically rich (equity is still rebuilding from COVID-era losses), debt/equity of 2.30x is high in absolute terms, and the 3-year average P/E window (only 3 years used) is distorted by the recovery years when trailing EPS was depressed. Net: the discount to history is real but roughly half of it is deserved — growth is decelerating to mid-single digits and the market is repricing cruise names for a maturing cycle.

The stock is pricing in a slowdown that the earnings haven't yet shown. Estimates went UP (FY2026 EPS guide raised from $17.10-$17.50 to $17.73-$17.87) while the price went DOWN 15.5% in a month — a pure multiple-compression move that has taken forward P/E from roughly 17-18x to 14.7x. That is either an overshoot (the company still grew Q2 revenue 6.5% with load factors at 110% and says 2027 bookings are pacing ahead of historical levels) or the market front-running a 2027 normalization in pricing and capacity. The resolution comes at the 2026-10-27 Q3 print: consensus EPS ~$6.32 must land, and 2027 booking commentary must stay positive, for the gap between the current 14.7x and the ~16-17x RCL historically earns to close. If Q3 misses or 2027 pacing commentary weakens, the de-rating is justified and there is no immediate floor until the $232.10 52-week low.

Textbook oversold-in-a-downtrend as of 2026-09-13. RSI(14) of 24.43 is well below 30, and price of $260.14 is below all three major moving averages — roughly 7.1% under the 20-day (~$280), 11.2% under the 50-day (~$293) and 9.7% under the 200-day (~$288). Losing the 200-day is the more meaningful signal: it says this is a structural trend break, not a two-week wobble. Momentum: -1.9% one week, -15.5% one month, -11.6% three months, -4.6% six months — the damage is concentrated in the last month. Entry-timing implication: an RSI below 25 after a 15% monthly drawdown invites a reflexive bounce, but with price beneath every moving average and the 50-day rolling toward the 200-day (a potential death cross), buying here is catching a falling knife. A more disciplined setup is either a reclaim of the ~$280 20-day, or a capitulation flush toward the $232.10 52-week low where the risk/reward is genuinely asymmetric.

• Consumer discretionary spending split: resilient high-end/experiential travel demand is offsetting pressure on lower-income consumers, which supports RCL's premium Caribbean and private-destination itineraries but leaves the whole thesis levered to a strong consumer.
• Geopolitical conflict in the Middle East and surrounding regions is causing localized booking friction and forced Mediterranean/European itinerary adjustments — the direct cause of the FY revenue growth guidance trim from ~10% to ~9%.
• Marine fuel and crude price volatility: Q2 2026 fuel expense rose year-over-year and gross margin compressed to 47.3% from 49.7%, despite slightly lower projected fuel consumption helping cushion the bottom line.
• Interest rates and credit conditions: S&P's upgrade to BBB (stable) with leverage near 2.6x lowers RCL's cost of capital, but $21.26B of long-term debt (up from $17.20B a year earlier) makes refinancing costs and rate expectations a live earnings variable.
• Industry-wide capacity additions — RCL's own Icon-class deliveries (Legend of the Seas launched July 2026) plus competitor newbuilds — mean the sector is adding berths; if demand growth slows, cruise pricing power normalizes and the current 110% load factors do not stay a bull argument by default.

• Q3 2026 earnings on 2026-10-27 (before market open), consensus EPS ~$6.32 — the single biggest test of whether the raised FY2026 guide of $17.73-$17.87 is achievable given the implied H2 acceleration.
• 2027 booking velocity commentary, which management says is pacing ahead of historical levels even on geopolitically affected itineraries — confirmation would directly attack the de-rating thesis.
• Capital return cadence: $1.50/share quarterly dividend (record date 2026-09-17, payable 2026-10-08) plus active share repurchases, which become more accretive if the stock stays depressed.
• Icon-class capacity ramp — Legend of the Seas (July 2026) and the remaining orderbook drive mid-single-digit capacity growth layered on top of yield growth into 2027-2028.
• Any de-escalation in the Middle East / Mediterranean that restores European summer itinerary confidence and reverses the localized booking drag management flagged.

• The deceleration is real and accelerating: revenue growth slid from +13.2% YoY (Q4 2025) to +11.3% (Q1 2026) to +6.5% (Q2 2026), and Q2 2026 delivered the first YoY operating-margin compression (27.0% vs. 29.3%) and first YoY net income decline (-6.8%) in over two years.
• Balance-sheet leverage: debt/equity of 2.30x, $21.26B of long-term debt (up $4.06B YoY to fund newbuilds), only $875M of cash, and a current ratio of 0.209 against $11.66B of current liabilities — thin liquidity relative to the asset base even if much of that liability is customer deposits.
• Negative trailing free cash flow: -$416M over the last four quarters, as $7.20B of capex (including $2.74B in Q2 2026 alone) outran $6.79B of operating cash flow. Growth is being funded from the balance sheet, and that persists as long as the Icon-class orderbook is being delivered.
• Cost and yield squeeze from fuel price volatility and geopolitical-driven itinerary changes, both of which management explicitly cited when trimming the revenue growth outlook.
• Valuation-multiple risk: beta of 1.75 and a 52-week range of $232.10-$356.39 mean a further de-rating (from 14.7x to peers' ~10-12x forward cruise multiples) is a bigger downside driver than an earnings miss.
• Sell-side conviction is thinner than the headline suggests: of 52 ratings, 21 are hold and 6 are sell, and the $348.09 consensus target rests on only 7 contributing price targets — a small base for a 34% upside claim.

RCL is a genuinely high-quality operator — 27.3% trailing operating margin, 23.6% net margin, 14.9% ROIC, 42.6% ROE, BBB-credit balance sheet, and load factors at 110% — that has been de-rated to 14.7x FY2026E EPS while its FY2026 EPS guidance was being RAISED. That combination is usually an opportunity, and it is not a cyclical-trough story (margins are near record highs, so the deterministic score's low marks are not a trough artifact). But the trend data is genuinely softening, not just noisy: revenue growth halved to +6.5% in Q2 2026, operating margin compressed year-over-year for the first time in two years, TTM free cash flow is -$416M on a heavy newbuild capex cycle, and the stock has lost its 200-day moving average. My read is that the next move is decided at the 2026-10-27 Q3 print and 2027 booking commentary — the risk/reward is favorable for a patient investor at $260 with RSI at 24, but this is a value opportunity-or-value-trap situation rather than a setup I'd chase, and the price action does not yet support a bullish call. This is analysis, not personalized financial advice.

I applied a 16.5x forward P/E to FY2026E EPS of $17.76 (the midpoint of management's raised $17.73-$17.87 guidance and the consensus next-FY figure), giving $293. The 16.5x sits ~15% below RCL's own 3-year average trailing P/E of 19.4x to reflect decelerating revenue growth (FY guidance trimmed from ~10% to ~9%) and 2.30x debt/equity, but above the 14.7x the 2026-09-13 price of $260.14 implies, reflecting ~14% FY2026 EPS growth, a 27.3% trailing operating margin, 14.9% ROIC and investment-grade BBB credit — and it deliberately comes in well below the Street's $348 consensus target (~19.6x implied), which I think underweights the multiple compression already underway.